U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H30N2O2.ClH
Molecular Weight 390.947
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BARUCAINIDE HYDROCHLORIDE

SMILES

Cl.CC(C)NCCCCOC1=C2COCC2=C(CC3=CC=CC=C3)N=C1C

InChI

InChIKey=NDUAUQZNHSFJMY-UHFFFAOYSA-N
InChI=1S/C22H30N2O2.ClH/c1-16(2)23-11-7-8-12-26-22-17(3)24-21(19-14-25-15-20(19)22)13-18-9-5-4-6-10-18;/h4-6,9-10,16,23H,7-8,11-15H2,1-3H3;1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C22H30N2O2
Molecular Weight 354.4858
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Barucainide, an IB anti-arrhythmic agent, was evaluated in patients with coronary artery disease. Its antiarrhythmic effect was studied in patients with markedly depressed left-ventricular function. Barucainide was in phase II clinical trials to treat the patients with arrhythmias but the development of the drug was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
[Effect of barucainide on left ventricular ejection fraction in patients with ventricular cardiac arrhythmias].
1991 Oct
Investigation of the pharmacokinetic behavior of barucainide in man during an early phase I study.
1992 Nov
Patents

Sample Use Guides

The pharmacokinetic behavior of the class Ib antiarrhythmic drug barucainide was investigated in a phase I study in a group of 6 healthy male volunteers after oral administration of an initial single dose of 20 mg and incremental doses between 30 and 70 mg barucainide hydrochloride.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:12:34 GMT 2023
Edited
by admin
on Fri Dec 15 15:12:34 GMT 2023
Record UNII
RFI1WXG626
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BARUCAINIDE HYDROCHLORIDE
Common Name English
4-((1,3-DIHYDRO-6-METHYL-4-(PHENYLMETHYL)FURO(3,4-C)PYRIDIN-7-YL)OXY)-N-(1-METHYLETHYL)-1-BUTANAMINE HYDROCHLORIDE
Systematic Name English
1-BUTANAMINE, 4-((1,3-DIHYDRO-6-METHYL-4-(PHENYLMETHYL)FURO(3,4-C)PYRIDIN-7-YL)OXY)-N-(1-METHYLETHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
301-208-7
Created by admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
PRIMARY
CAS
93982-17-3
Created by admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
PRIMARY
FDA UNII
RFI1WXG626
Created by admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
PRIMARY
EPA CompTox
DTXSID40240120
Created by admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
PRIMARY
PUBCHEM
146794
Created by admin on Fri Dec 15 15:12:34 GMT 2023 , Edited by admin on Fri Dec 15 15:12:34 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY